SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,132.81 -382.62
( -0.50%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

39.9450037

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

10.83

33.47

EPS(TTM)

Face Value()

Div & Yield %

3.6

Back

Gabriel India consolidated net profit rises 1.99% in the June 2026 quarter

Jul 22,2026

Net profit of Gabriel India rose 1.99% to Rs 107.35 crore in the quarter ended June 2026 as against Rs 105.26 crore during the previous quarter ended June 2025. Sales rose 15.50% to Rs 1425.68 crore in the quarter ended June 2026 as against Rs 1234.36 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1425.68	1234.36	15
OPM %	8.71	9.58	-
PBDT	165.56	156.43	6
PBT	133.26	125.78	6
NP	107.35	105.26	2

76,132.81 -382.62 ( -0.50%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

66,225.50 1,204.56 (1.85%)

10,817.95 -13.14 (-0.12%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)